Brief: Bioporto Says To Provide More Patient Information In Support Of Application For Clearance Of Ngal Test For Pediatric Risk Assessment Of Acute Kidney Injury

BioPorto A/S

18/11/2019 19:27

Nov 18 (Reuters) - Bioporto A/S  BIOPOR.CO :
    * TO PROVIDE MORE PATIENT INFORMATION IN SUPPORT OF APPLICATION FOR CLEARANCE OF NGAL TEST
FOR
PEDIATRIC RISK ASSESSMENT OF ACUTE KIDNEY INJURY
    * CO EXPECTS TO SUBMIT A REVISED AND SUPPLEMENTED APPLICATION IN Q2 2020, WITH ADULT
APPLICATION
TO FOLLOW
    * GUIDANCE TO CHANGE FROM REVENUE OF ABOUT DKK 32 MILLION TO ABOUT DKK 29 MILLION, 2019 EBIT
TO
CHANGE FROM LOSS OF ABOUT DKK 65 MILLION TO LOSS OF ABOUT DKK 70 MILLION

Source text for Eikon:  ID:nGNE53b6yf 
Further company coverage:  BIOPOR.CO 

 ((Reuters.Briefs@thomsonreuters.com;))